Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade

FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index (CLL-IPI) and in directing therapy with novel agents. However, testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiayu, Yang, Lin, Tordon, Bryan, Bucher, Oliver, Nugent, Zoann, Landego, Ivan, Bourrier, Nicole, Uminski, Kelsey, Brown, Kevin, Squires, Mandy, Marshall, Aaron J., Katyal, Sachin, Mahmud, Salah, Decker, Kathleen, Geirnaert, Marc, Dawe, David E., Gibson, Spencer B., Johnston, James B., Banerji, Versha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378068/
https://www.ncbi.nlm.nih.gov/pubmed/37504332
http://dx.doi.org/10.3390/curroncol30070472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378068/
https://www.ncbi.nlm.nih.gov/pubmed/37504332
http://dx.doi.org/10.3390/curroncol30070472

Ejemplares similares